Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1312815-95-4

Post Buying Request

1312815-95-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1312815-95-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1312815-95-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,8,1 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1312815-95:
(9*1)+(8*3)+(7*1)+(6*2)+(5*8)+(4*1)+(3*5)+(2*9)+(1*5)=134
134 % 10 = 4
So 1312815-95-4 is a valid CAS Registry Number.

1312815-95-4Relevant articles and documents

Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation

Arhancet, Graciela B.,Walker, Daniel P.,Metz, Sue,Fobian, Yvette M.,Heasley, Steven E.,Carter, Jeffrey S.,Springer, John R.,Jones, Darin E.,Hayes, Michael J.,Shaffer, Alexander F.,Jerome, Gina M.,Baratta, Michael T.,Zweifel, Ben,Moore, William M.,Masferrer, Jaime L.,Vazquez, Michael L.

, p. 1114 - 1119 (2013/03/14)

Inhibition of mPGES-1, the terminal enzyme in the arachidonic acid/COX pathway to regulate the production of pro-inflammatory prostaglandin PGE2, is considered an attractive new therapeutic target for safe and effective anti-inflammatory drugs. The discovery of a novel series of orally active, selective benzoxazole piperidinecarboxamides as mPGES-1 inhibitors is described. Structure-activity optimization of lead 5 with cyclohexyl carbinols resulted in compound 12, which showed excellent in vitro potency and selectivity against COX-2, and reasonable pharmacokinetic properties. Further SAR studies of the benzoxazole ring substituents lead to a novel series of highly potent compounds with improved PK profile, including 23, 26, and 29, which were effective in a carrageenan-stimulated guinea pig air pouch model of inflammation. Based on its excellent in vitro and in vivo pharmacological, pharmacokinetic and safety profile and ease of synthesis, compound 26 (PF-4693627) was advanced to clinical studies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1312815-95-4